Usp Bupivacaine Hydrochloride Injection

NSN: 6505-00-149-3502 | Model: NDC00074-1582-30

NSN Properties and Flags

NATO Stock Number

6505-00-149-3502

DEMIL

Active Medicament Medicinal Strength

0.750 percentage, w/v bupivacaine hydrochloride active ingredient

Pharmaceutical Vehicle Type

Aqueous

Primary Container Type

Ampul

Primary Container Content Quantity

30.000 milliliters

Total Primary Container Quantity

Administration

Nerve block

Part Name Assigned By Controlling Agency

Bupivacaine hydrochloride injection 0.75% 30ml ampul 5 ampuls bx

Supplementary Features

Single-dose vial

Pricing and Availability

Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.

Certified Quality Assurance

ISO 9001:2015 + AS9120B
Counterfeit Parts Prevention
100% Product Inspections
7 Year Record Retention
On Time Delivery
HAZMAT Certified
Worldwide Shipping

NSN 6505-00-149-3502 Datasheet

Supply Class (FSC):

Drugs And Biologicals

Cross Reference:

NDC00074-1582-30
NDC00074-1582-30
NDC00024-1214-02

Cage Codes:

Cardinal Health 200, Llc (CAGE 07TA6)
Hospira, Inc. (CAGE 3VBU6)
Synthelabo Inc Sanofi (CAGE 63240)

Replacements:

6505-00-149-3502 replaces 6505-00-336-7912

Schedule B & Trade:

Schedule B: 3004909130 (NAICS 325412)

Anticonvulsants, hypnotics and sedatives, primarily affecting central nervous system, put up in measured doses or in forms or packings for retail sal
SITC: 54293

Medicaments, n.E.S., in dosage form or retail packings
End Use: 40100

Pharmaceutical preparations

Identification:

HMIC

Y - Indicates information is in the hazardous materials information resource system (hmirs).

PMIC

A - Item does not contain precious metal.

CRITL

- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.

Freight Information:

NMFC:

058770 - Drugs/medicines/vitamins noi
WCC:

532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
SHC:

9 - Other or no special handling required (sh)
ADC:

A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
ACC:

M - Medical supplies, equipment, samples, records, etc.
LTL:

W - Rating variable
TCC:

Z - No special type of cargo code applicable

NSN Management Codes:

SOS
Sms
AAC
L
Quantity per pack
No qup
Unit of Measure
Bx
Shelf Life
24 mo.
Classification Control
U
MGMT_CTL
1-54---
Repariability
This is a nonreparable item. if condemned or economically unserviceable, then dispose at the level authorized replace the item.

Questions & Answers:
What are the historical prices recorded for this stock number?
Historical data shows pricing from $65.12 to $108.54..
Does NSN 6505-00-149-3502 have a shelf life?
No. There is no shelf life applicable for this NSN.
What NATO entities are users of this NSN?
Department Of The Army, Department Of The Air Force, U.s. Marine Corps, Department Of The Navy, and Kuwait
What is the NIIN of NSN 6505-00-149-3502?
001493502 or 00-149-3502
Does NSN 6505-00-149-3502 require demilitarization?
Yes - ITAR Controlled
What is the most recent solicitation for NSN 6505-00-149-3502?
No solicitations for this NSN.
When was this national stock number assigned to the federal catalog?
Oct 27, 1974

Material Safety

MSDS BWMPL BUPIVACAINE HYDROCHLORIDE INJ.,USP

Hazards

Ld50 lc50 mixture: ld50=18mg/kg,rabbit,oral-bupivacaine hcl
routes of entry: inhalation: no skin: no ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: contains bupivacaine hydrochloride in
aqu soln.Health related data for prod based on bupivacaine
hydrochloride content.Loc anesthetic that produces anesthesia
(numbuness) by blockage of nerve conducti on & adversely affect cns
& heart.

explanation of carcinogenicity: per
msds: carcinogenicity: ntp/iarc/osha/acgih: not listed.

effects of overexposure: none from intact vials. In clinical use effects
include numbnes, dizz, restlessness, excitation/depress, anxiety,
tinnitis, blurred vision, tremors, convulsions, hypotension,
bradycardia, ventricular arrhythmias, heart block, and cardiac
arrest.

medical cond aggravated by exposure: data suggest pre-existing central
nervous system or cardiovascular ailments. Hypersensitivity to
amide-type local anesthetics.

First Aid

First aid: remove from source of exposure. Skin/eye contact occurs flush
w/copious amts of water. If irrit persists or signs of toxicity
occur seek med attn. No known antidote. Provide
symptomatic/supportive car e, maintaining ventilation,
controllingconvulsions, and monitoring cardiovascular function, as
necessary.

Chemical Properties

Hcc: n1
boiling pt: b.P. Text: water(aprx)
melt/freeze pt: m.P/f.P text: water(aprx)
spec gravity: water(approx)
ph: 4.-6.5
viscosity: water(approx)
solubility in water: aqueous solution
appearance and odor: clear liquid.

percent volatiles by volume: nelgig

Reactivity

None.

stability condition to avoid: none.

hazardous decomposition products: none.

Proper Disposal

Waste disposal methods: no special requirements.

disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ingredients List

Ingred name: bupivacaine hydrochloride
cas: 18910-40-7
other rec limits: none recommended

ingred name: aqueous solution
other rec limits: none recommended